Clinical Trials on CML, Accelerated Phase
Total 1560 results
-
Onco Medical Consult GmbHCompletedTreating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib (DasPAQT)Myeloid Leukemia, Chronic, Chronic-PhaseGermany
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
Cancer Trials IrelandCompletedLeukemiaUnited States, Ireland, Israel, Germany
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
M.D. Anderson Cancer CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedLeukemia, Myeloid, ChronicUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
PETHEMA FoundationCompleted
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
University of PennsylvaniaCompletedMultiple Myeloma | AML | MDS | NHL | CML | Hodgkin's Disease | ALLUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Sheffield Children's NHS Foundation TrustWithdrawnGene Expression Profiles in CML Non-respondersUnited Kingdom
-
Newave Pharmaceutical IncActive, not recruitingRefractory Acute Lymphoblastic Leukemia | Relapse | CMML | Relapsed Adult AML | AML/MDS | Relapse LeukemiaUnited States, Spain
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingLymphoblastic Lymphoma | Childhood Acute Myeloid Leukemia in Remission | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.RecruitingChronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive | BCR-ABL1 Positive Chronic Myelogenous Leukemia | BCR-ABL1 PositiveUnited States
-
AstraZenecaActive, not recruitingPhase I: Relapsed or Refractory B-cell Malignancies | Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma | Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic LeukemiaChina
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Lymphocytic Leukemia | MDS (Myelodysplastic Syndrome) | CLL (Chronic Lymphocytic Leukemia) | CML (Chronic Myelogenous Leukemia) | AML (Acute Myelogenous Leukemia)United States
-
UMC UtrechtNot yet recruitingPregnancy Related | Fertility Issues | Luteal Phase Defect | Infertility Unexplained
-
Technische Universität DresdenAbbVieActive, not recruitingRelapsed Adult AML | Refractory AMLGermany
-
Universidade Federal do Rio de JaneiroMinistry of Health, Brazil; National Research Council, Brazil; Ministry of Science...CompletedChronic and Accelerated SilicosisBrazil
-
Seoul St. Mary's HospitalBristol-Myers SquibbRecruitingChronic Myelocytic LeukemiaKorea, Republic of
-
University of PisaCompletedDiabetes | PeriodontitisItaly
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Bristol-Myers SquibbWithdrawnMyeloid Leukemia, Chronic, Chronic-PhaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Myelodysplastic Syndrome... and other conditionsUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruitingValidity and SafetyChina
-
Jonsson Comprehensive Cancer CenterBristol-Myers SquibbCompleted
-
Emory UniversityTerminatedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Anhui Medical UniversityRecruitingTranscranial Magnetic Stimulation | Obsessive-Compulsive Disorder | Functional Magnetic Resonance Imaging | Accelerated Continue Theta-burst StimulationChina
-
Asan Medical CenterKorean Health Technology R&D Project, Ministry of Health & WelfareCompletedBipolar Disorder | Heart Rate Variability | Subsyndromal Depressive PhaseKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
PfizerCompletedPharmacokinetics | Safety | Phase 1 | Single Dose | TolerationBelgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedCML | Nilotinib | Imatinib Resistant | Imatinib IntolerantKorea, Republic of
-
Leslie SwansonNational Institute of Mental Health (NIMH); University of Michigan; NatrolNot yet recruitingBipolar Disorder | Delayed Sleep-Wake Phase DisorderUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedMultiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALLUnited States
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Proximagen, LLCTerminatedSolid Tumors (Phase 1) | Relapsed/Recurrent GBM (Phase 2)United States, Spain
-
Hospices Civils de LyonCompletedChronic Myelogenous LeukemiaFrance
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); Stanford UniversityRecruiting
-
Carbiogene Therapeutics Co. Ltd.Zhejiang Provincial People's HospitalRecruiting
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)RecruitingCMML | AML With Monocytic DifferentiationUnited States
-
Nordsjaellands HospitalYale University; Rigshospitalet, Denmark; BioIncept LLCCompletedPregnancy | Biomarkers | Abortion, Habitual | Abortion, Spontaneous | Luteal Phase